| Upcoming events on ROCHE HOLDING AG |
|
| 07/22/21 | | |
| 09/09/21 | | |
| 09/15/21 | | |
| 09/17/21 | | |
|
| Past events on ROCHE HOLDING AG |
|
| 06/22/21 | 02:30am | | |
| 06/21/21 | 11:00am | | |
| 06/21/21 | 10:45am | | |
| 06/21/21 | 10:45am | | |
|
| Upcoming sector events for ROCHE HOLDING AG |
|
|
| |
|
| Past sector events for ROCHE HOLDING AG |
|
|
|
|
|
| Fiscal Period : December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 |
Sales
M CHF |
Released
Forecast
Spread | 50 576
50 686
-0,22% | 53 299
53 126
0,33% | 56 846
56 448
0,70% | 61 466
61 789
-0,52% | 58 323
59 276
-1,6% |
60 597
|
Operating income
(EBITDA)
M CHF |
Released
Forecast
Spread | 20 483
20 420
0,31% | 21 201
20 725
2,3% | 22 825
22 398
1,9% | 25 419
24 199
5,0% | 24 281
24 532
-1,0% |
25 246
|
Operating profit
(EBIT)
M CHF |
Released
Forecast
Spread | 18 420
18 651
-1,2% | 19 012
19 361
-1,8% | 20 505
20 431
0,36% | 22 479
22 680
-0,89% | 21 536
21 622
-0,40% |
22 266
|
Pre-Tax Profit
(EBT)
M CHF |
Released
Forecast
Spread | 13 007
14 865
-12% | 12 248
14 738
-17% | 14 148
17 012
-17% | 16 614
18 369
-9,6% | 17 965
18 289
-1,8% |
18 788
|
Net income
M CHF |
Released
Forecast
Spread | 9 576
10 611
-9,8% | 8 633
10 674
-19% | 10 500
12 780
-18% | 13 497
14 257
-5,3% | 14 295
14 335
-0,28% |
14 513
|
EPS
CHF |
Released
Forecast
Spread | 11,1
12,6
-12% | 10,0
12,5
-20% | 12,2
15,3
-20% | 15,6
16,6
-5,7% | 16,5
16,5
-0,02% |
17,2
| | Announcement Date | 02/01/2017 | 02/01/2018 | 01/31/2019 | 01/30/2020 | 02/04/2021 | - |
|
|
|
| Fiscal Period : December | 2016 S1 | 2016 S2 | 2017 S1 | 2017 S2 | 2018 S1 | 2018 Q3 | 2018 Q4 | 2018 S2 | 2019 Q1 | 2019 Q2 | 2019 S1 | 2019 Q3 | 2019 Q4 | 2019 S2 | 2020 Q1 | 2020 Q2 | 2020 S1 | 2020 Q3 | 2020 Q4 | 2020 S2 | 2021 Q1 | 2021 Q2 | 2021 Q3 | 2021 Q4 | 2021 S1 | 2021 S2 | 2022 Q1 |
Sales
M CHF |
Released
Forecast
Spread | 25 020
24 829
0,77% | 26 000
25 660
1,3% | 26 344
26 127
0,83% | 26 955
26 762
0,72% | 28 111
27 568
2,0% | 13 969
13 830
1,0% | 14 766
14 534
1,6% | 28 735
28 366
1,3% | 14 826
14 390
3,0% | 15 643
15 467
1,1% | 30 469
30 275
0,64% | 15 597
15 083
3,4% | 15 400
15 852
-2,8% | 30 997
31 426
-1,4% | 15 143
14 736
2,8% | 14 138
14 989
-5,7% | 29 281
30 369
-3,6% | 14 698
15 091
-2,6% | 14 344
15 207
-5,7% | 29 042
30 037
-3,3% |
14 963
|
15 012
|
14 818
|
14 606
|
|
|
14 619
|
Operating income
(EBITDA)
M CHF |
Released
Forecast
Spread | 9 850
9 608
2,5% | 8 570
8 714
-1,7% | 10 135
9 914
2,2% | 8 877
9 153
-3,0% | 11 162
10 480
6,5% |
|
| 9 343
9 269
0,80% |
|
| 12 363
11 862
4,2% |
|
| 10 116
10 525
-3,9% |
|
| 11 766
11 824
-0,49% |
|
| 9 770
9 915
-1,5% |
|
|
|
|
11 877
|
11 236
|
|
Operating profit
(EBIT)
M CHF |
Released
Forecast
Spread |
|
|
|
|
|
|
| 4 654
8 143
-43% |
|
| 10 354
11 145
-7,1% |
|
| 6 260
9 758
-36% |
|
| 10 181
10 632
-4,2% |
|
| 7 784
9 124
-15% |
|
|
|
|
10 758
|
10 056
|
|
Pre-Tax Profit
(EBT)
M CHF |
Released
Forecast
Spread | 5 378
6 022
-11% |
| 5 477
6 764
-19% |
|
|
|
| 3 191
6 551
-51% |
|
| 8 619
8 910
-3,3% |
|
| 4 878
6 896
-29% |
|
| 8 079
8 713
-7,3% |
|
| 6 216
7 084
-12% |
|
|
|
|
8 192
|
7 715
|
|
Net income
|
Released
Forecast
Spread | 6,24
7,28
-14% | 4,89
6,40
-24% | 6,37
7,06
-9,7% | 3,67
6,38
-42% | 8,51
8,26
3,0% |
|
| 3,70
7,29
-49% |
|
| 9,99
9,66
3,4% |
|
| 5,63
7,56
-26% |
|
| 9,32
9,70
-3,9% |
|
| 7,20
8,06
-11% |
|
|
|
|
9,48
|
8,94
|
| | Announcement Date | 07/21/2016 | 02/01/2017 | 07/27/2017 | 02/01/2018 | 07/26/2018 | 10/17/2018 | 01/31/2019 | 01/31/2019 | 04/17/2019 | 07/25/2019 | 07/25/2019 | 10/16/2019 | 01/30/2020 | 01/30/2020 | 04/22/2020 | 07/23/2020 | 07/23/2020 | 10/15/2020 | 02/04/2021 | 02/04/2021 | 04/21/2021 | - | - | - | - | - | - | |
|
|
|
|
|
Roche buys GenMark for $1.8 million to challenge test rivals |
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise
|
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Report
Previous year
